Results 211 to 220 of about 121,431 (264)

Emerging Chimeric Antigen Receptor-Immune Cell Therapy for Pancreatic Cancer: Mechanisms, Clinical Advances, and Future Perspectives. [PDF]

Oncol Res
Wang S, Wang M, Yao W.
europepmc   +1 more source

Nanobodies as next‐generation targeting platforms: From discovery technologies to translational biomedicine

VIEW, EarlyView.
Nanobodies, derived from the variable domains of camelid heavy‐chain‐only antibodies, have emerged as transformative biomedical tools due to their nanoscale size, exceptional stability, and unique capacity to recognize cryptic epitopes. This review provides a comprehensive overview of the field, outlining the structural and biochemical features of ...
Zhenrui Ye, Xianyang Li, Meixiao Zhan
wiley   +1 more source

Viral Reactivation in Multiple Myeloma Patients Receiving Anti-BCMA Chimeric Antigen Receptor T-Cell Therapy. [PDF]

Int J Mol Sci
Cohen I, Lebel E, Grisariu S, Avni B, Kfir-Erenfeld S, Asherie N, Zimran E, Vainstein V, Assayag M, Sharon TD, Alexander-Shani R, Bessig N, Shehadeh A, Ishtay A, Schlossberg M, Pick M, Gatt ME, Bdolah-Abram T, Stepensky P, Elias S.   +19 more
europepmc   +1 more source

Nanomedicine applications in lymphoma: Advancing precision diagnostics, targeted therapeutics, and prospective developments

VIEW, EarlyView.
Lymphoma is a group of blood cancers that can appear in lymph nodes, blood, bone marrow, spleen, liver, or the central nervous system, which makes drug delivery and disease monitoring difficult. This review summarizes how nanomedicine technologies may improve targeted treatment and imaging, while carefully separating approved or guideline‐supported ...
Mohd Ahmar Rauf, Yara Mashal, Afeefa Rao, Nasar Ata, Arun K. Iyer, Farhan Shah   +5 more
wiley   +1 more source

Chimeric antigen receptor-based cell therapy for treating urological tumors. [PDF]

Curr Urol
Tang H, Guo L, Zhang W, Tang D.
europepmc   +1 more source

Chimeric antigen receptor T cell therapy: Revolutionizing cancer treatment. [PDF]

World J Clin Oncol
Arjumand S, Raj A, Prattay KMR, Omer HBM, Azam F.   +4 more
europepmc   +1 more source

Chimeric antigen receptor (CAR) therapies for precise eradication of pathogenic cells in autoimmunity. [PDF]

Arthritis Res Ther
Kalliolias GD, Basdra EK, Papavassiliou AG.   +2 more
europepmc   +1 more source

A global multidimensional analysis of the chimeric antigen receptor T-cell therapy clinical trial landscape and development trends. [PDF]

Biomark Res
Lai C, Hu J, Wu Z, He K, Li J, Zhu W, Liu C, He W, Xu K.   +8 more
europepmc   +1 more source

Teclistamab interference with anti-BCMA chimeric antigen receptor T-cell detection by flow cytometry: duration and clinical implications. [PDF]

Leukemia
Schadt J, von Bonin M, Oelschlägel U, Teipel R, Epp K, Saalfeld FC, Schulze F, Heuschkel S, Bornhäuser M, Röhnert MA.   +9 more
europepmc   +1 more source

Chimeric antigen receptor dendritic cells suppress melanoma growth in preclinical cancer models. [PDF]

J Immunother Cancer
Minnee J, Wong WZ, Russell BS, Semana JL, Li R, Landau NR, Tada T.   +6 more
europepmc   +1 more source